Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Facioscapulohumeral Muscular Dystrophy 2”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Not applicableStudy completedNCT02032979
What this trial is testing

Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Centre Hospitalier Universitaire de Nice 6
Large-scale testing (Phase 3)Looking for participantsNCT07038200
What this trial is testing

Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

Who this might be right for
Facioscapulohumeral Muscular DystrophyFSHDFSHD - Facioscapulohumeral Muscular Dystrophy+14 more
Avidity Biosciences, Inc. 200
Testing effectiveness (Phase 2)Ended earlyNCT04264442
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 76
Testing effectiveness (Phase 2)Looking for participantsNCT06907875
What this trial is testing

A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Epicrispr Biotechnologies, Inc. 12
Testing effectiveness (Phase 2)Ended earlyNCT02927080
What this trial is testing

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 95
Not applicableLooking for participantsNCT06708468
What this trial is testing

Personalized Training for People With Rare Neuromuscular Disorders

Who this might be right for
Neuromuscular Diseases (NMD)Charcot Marie Tooth Disease (CMT)Facioscapulohumeral Muscular Dystrophy+1 more
Oslo University Hospital 120
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06547216
What this trial is testing

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 84
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableLooking for participantsNCT00082108
What this trial is testing

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Who this might be right for
Myotonic DystrophyFacioscapulohumeral Muscular DystrophyMuscular Dystrophy+6 more
University of Rochester 3,000
Not applicableStudy completedNCT01970735
What this trial is testing

Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Centre Hospitalier Universitaire de Nice 103
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07435129
What this trial is testing

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

Who this might be right for
Facioscapulohumeral Muscular DystrophyFSHD
Scholar Rock, Inc. 60
Not applicableLooking for participantsNCT06079567
What this trial is testing

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

Who this might be right for
Facioscapulohumeral Muscular Dystrophy Type 2
Centre Hospitalier Universitaire de Nice 50
Not applicableLooking for participantsNCT06078852
What this trial is testing

Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients

Who this might be right for
FSHD1FSHD2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 34
Testing effectiveness (Phase 2)Study completedNCT04003974
What this trial is testing

Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 80
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Large-scale testing (Phase 3)Ended earlyNCT05397470
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 260
Not applicableLooking for participantsNCT07409142
What this trial is testing

BetterLife FSHD: A Patient-driven Health and Research Platform

Who this might be right for
FSHFSH Muscular DystrophyFSHD - Facioscapulohumeral Muscular Dystrophy+8 more
FSHD Society 5,000
Not applicableStudy completedNCT02948244
What this trial is testing

Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHD

Who this might be right for
Facio-Scapulo-Humeral DystrophyFSHD2FSHD1
Murdoch Childrens Research Institute 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05747924
What this trial is testing

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 90
Not applicableLooking for participantsNCT06911190
What this trial is testing

Ten Year Follow-up in FSHD: the FOCUS 3 Study

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Radboud University Medical Center 200
Load More Results